* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Monday, August 4, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    Exclusive | Fox Takes Stake in IndyCar Owner Penske Entertainment – The Wall Street Journal

    Exclusive | Fox Takes Stake in IndyCar Owner Penske Entertainment – The Wall Street Journal

    Go-to entertainment: why gaming was made for the toilet – The Guardian

    Why Gaming Is the Ultimate Way to Pass Time in the Bathroom

    Chicago Youth Symphony Orchestra takes the Lollapalooza stage – Yahoo Home

    Chicago Youth Symphony Orchestra takes the Lollapalooza stage – Yahoo Home

    Sens. Blackburn, Warnock introduce CREATE Act to provide tax relief to music creators – Yahoo Home

    Sens. Blackburn and Warnock Launch CREATE Act to Deliver Tax Relief for Music Creators

    That’s (Political) Entertainment: When Theatre Meets Politics

    Future Script: How Generative AI Is Changing Collective Bargaining in the Entertainment Industry – Jackson Lewis

    Future Script: How Generative AI Is Transforming Collective Bargaining in Entertainment

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Credo Technology: Wiring The AI Revolution (NASDAQ:CRDO) – Seeking Alpha

    Credo Technology: Driving the Next Wave of AI Innovation

    Microsoft Seeks to Extend Access to OpenAI Technology – PYMNTS.com

    Microsoft Aims to Broaden Access to OpenAI Technology

    Livonia police use grappler technology to stop drunk driver – ClickOnDetroit | WDIV Local 4

    Livonia Police Deploy Grappler Technology to Safely Stop Drunk Driver

    Emory orthopaedic surgeons use robotic technology to transform knee replacement surgery – Emory News Center

    How Robotic Technology is Revolutionizing Knee Replacement Surgery

    Cognizant Technology Solutions Corp (CTSH) Q2 2025 Earnings Call Highlights: Strong Revenue … – Yahoo.co

    Cognizant Q2 2025 Earnings: Impressive Revenue Growth and Key Takeaways

    Revving Up The U.S. Technology Engine – Forbes

    Revving Up The U.S. Technology Engine – Forbes

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    Exclusive | Fox Takes Stake in IndyCar Owner Penske Entertainment – The Wall Street Journal

    Exclusive | Fox Takes Stake in IndyCar Owner Penske Entertainment – The Wall Street Journal

    Go-to entertainment: why gaming was made for the toilet – The Guardian

    Why Gaming Is the Ultimate Way to Pass Time in the Bathroom

    Chicago Youth Symphony Orchestra takes the Lollapalooza stage – Yahoo Home

    Chicago Youth Symphony Orchestra takes the Lollapalooza stage – Yahoo Home

    Sens. Blackburn, Warnock introduce CREATE Act to provide tax relief to music creators – Yahoo Home

    Sens. Blackburn and Warnock Launch CREATE Act to Deliver Tax Relief for Music Creators

    That’s (Political) Entertainment: When Theatre Meets Politics

    Future Script: How Generative AI Is Changing Collective Bargaining in the Entertainment Industry – Jackson Lewis

    Future Script: How Generative AI Is Transforming Collective Bargaining in Entertainment

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Credo Technology: Wiring The AI Revolution (NASDAQ:CRDO) – Seeking Alpha

    Credo Technology: Driving the Next Wave of AI Innovation

    Microsoft Seeks to Extend Access to OpenAI Technology – PYMNTS.com

    Microsoft Aims to Broaden Access to OpenAI Technology

    Livonia police use grappler technology to stop drunk driver – ClickOnDetroit | WDIV Local 4

    Livonia Police Deploy Grappler Technology to Safely Stop Drunk Driver

    Emory orthopaedic surgeons use robotic technology to transform knee replacement surgery – Emory News Center

    How Robotic Technology is Revolutionizing Knee Replacement Surgery

    Cognizant Technology Solutions Corp (CTSH) Q2 2025 Earnings Call Highlights: Strong Revenue … – Yahoo.co

    Cognizant Q2 2025 Earnings: Impressive Revenue Growth and Key Takeaways

    Revving Up The U.S. Technology Engine – Forbes

    Revving Up The U.S. Technology Engine – Forbes

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

FDA Panel Reluctantly Backs Patisiran for ATTR Cardiomyopathy

September 14, 2023
in Health
FDA Panel Reluctantly Backs Patisiran for ATTR Cardiomyopathy
Share on FacebookShare on Twitter

FDA advisors conceded on Wednesday that the benefit-risk balance of patisiran (Onpattro) technically checks out in wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM, also known as cardiac ATTR amyloidosis) — though they were unconvinced that the benefits are actually meaningful.

At the end of the day, the Cardiovascular and Renal Drugs Advisory Committee ultimately voted 9-3 that patisiran’s benefits outweigh its risks in ATTR-CM, with members expressing minimal concern about the safety of the RNA interference agent from Alnylam Pharmaceuticals. The panel’s majority-yes votes were commonly attributed to the technicality of the question.

There is a “light wind for benefit and no wind for risk, so if you’re asking do benefits outweigh the risks, the answer is yes,” said Edward Kasper, MD, of Johns Hopkins School of Medicine in Baltimore.

Kasper suggested that patisiran would likely be a “niche” product at best, however, as its evidence is limited to monotherapy and not as a rescue for patients not responding to tafamidis (Vyndaqel or Vyndamax), the existing standard-of-care medication indicated to reduce cardiovascular mortality and cardiovascular-related hospitalization in ATTR-CM.

The crux of the issue is whether patisiran has enough benefit in cardiomyopathy to merit an expansion of its existing indication for polyneuropathy in ATTR amyloidosis.

Committee chairperson Javed Butler, MD, MPH, MBA, of the University of Mississippi Medical Center in Jackson, said he voted no because he was not sure if patisiran’s benefits were clinically meaningful, a recurring remark among fellow panelists throughout the day.

Patisiran’s application for an expanded indication rests on the phase III APOLLO-B trial showing small gains in 6-minute walk test (6MWT) and health status and quality of life (as measured by the Kansas City Cardiomyopathy Questionnaire) — none meeting subjective thresholds for clinical significance — when comparing the gene silencer with placebo.

“What level of evidence would I give this? This wouldn’t be a I or IIa. It would be IIb. The level of evidence is not high here,” Kasper said.

Notably, APOLLO-B showed that these small benefits did not apply to people on background tafamidis. Like tafamidis, patisiran is intended to stop or slow the progression of cardiac amyloidosis.

The argument that nonresponders to tafamidis could be helped by having an alternate option in patisiran was shot down by Butler, who pointed out the negative interaction in the trial suggesting that patients in New York Heart Association class III — likely those progressing nonresponders — were a subgroup that did not see benefit in 6MWT.

“That makes the interpretation a little bit difficult, to say that the nonresponders are definitely going to respond to patisiran therapy,” he said.

Moreover, some said it would be an indirect safety concern if patients mistook patisiran to be a viable alternative to tafamidis. “I would hate to see any unintended consequences if patients don’t get put on tafamidis because of this drug, so I do think there could be harm,” said David Moliterno, MD, of the University of Kentucky Medical Center in Lexington, adding that he did ultimately vote yes.

And while there may not be direct safety risks with the drug, there is nevertheless potential harm and the cost, time, and effort needed for an IV infusion every 3 weeks for patisiran therapy, suggested C. Noel Bairey Merz, MD, of Cedars-Sinai Medical Center in Los Angeles, who voted no.

ATTR-CM is a rare, rapidly progressive disease caused by a gene mutation resulting in misfolded transthyretin protein and excess amyloid buildup in the heart and other organs.

Patisiran works by blocking the production of transthyretin protein and is already FDA approved for treating polyneuropathy associated with hereditary ATTR amyloidosis. It won this initial approval in 2018 based on its ability to slow the progression of peripheral neuropathy in patients with hereditary ATTR amyloidosis over 18 months in the APOLLO trial.

Some expect more from future therapies in this arena, as recently reported cases of spontaneous reversal suggest it is possible for amyloid to be cleared from the heart using antibody treatment, for a return to near-normal cardiac structure and function without scarring.

author['full_name']

Nicole Lou is a reporter for MedPage Today, where she covers cardiology news and other developments in medicine. Follow

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : MedPageToday – https://www.medpagetoday.com/cardiology/chf/106325

Tags: healthPanelReluctantly
Previous Post

IMRT Best for Locally Advanced NSCLC, Study Suggests

Next Post

Acetazolamide May Help COPD Patients Reach New Heights

New rule would expand tug escort requirements, reduce risk of oil spills in Puget Sound – Washington State Department of Ecology (.gov)

New Rule Strengthens Tug Escort Requirements to Drastically Reduce Oil Spill Risks in Puget Sound

August 4, 2025
100 years ago, scientists thought we’d be eating food made from air – Popular Science

A Century Ago, Scientists Predicted We’d Be Eating Food Made from Air

August 4, 2025
Maserati and Sparco Launch Lifestyle Capsule Inspired by Motorsport Heritage – stupidDOPE

Maserati and Sparco Launch Lifestyle Capsule Inspired by Motorsport Heritage – stupidDOPE

August 4, 2025
Fox News Flash top entertainment headlines of the week – Fox News

Top Entertainment Headlines You Can’t Miss This Week

August 4, 2025
How Is the Economy Doing Right Now? – NerdWallet

What’s Really Going On with the Economy Right Now?

August 4, 2025
Exclusive | Fox Takes Stake in IndyCar Owner Penske Entertainment – The Wall Street Journal

Exclusive | Fox Takes Stake in IndyCar Owner Penske Entertainment – The Wall Street Journal

August 4, 2025
At Washington Health Care Authority, workers are warned of layoffs – Washington State Standard

Washington Health Care Authority Alerts Employees of Potential Layoffs

August 4, 2025
NYPD program allowed slain officer to moonlight as private security guard – Spectrum News NY1

NYPD program allowed slain officer to moonlight as private security guard – Spectrum News NY1

August 4, 2025
Credo Technology: Wiring The AI Revolution (NASDAQ:CRDO) – Seeking Alpha

Credo Technology: Driving the Next Wave of AI Innovation

August 3, 2025
Judge Halts Stephen F. Austin’s Female Sports Cuts Amid Title IX Suit – Sportico.com

Judge Halts Stephen F. Austin’s Female Sports Cuts Amid Title IX Suit – Sportico.com

August 3, 2025

Categories

Archives

August 2025
MTWTFSS
 123
45678910
11121314151617
18192021222324
25262728293031
« Jul    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (753)
  • Economy (778)
  • Entertainment (21,655)
  • General (16,273)
  • Health (9,815)
  • Lifestyle (786)
  • News (22,149)
  • People (777)
  • Politics (787)
  • Science (15,991)
  • Sports (21,273)
  • Technology (15,755)
  • World (759)

Recent News

New rule would expand tug escort requirements, reduce risk of oil spills in Puget Sound – Washington State Department of Ecology (.gov)

New Rule Strengthens Tug Escort Requirements to Drastically Reduce Oil Spill Risks in Puget Sound

August 4, 2025
100 years ago, scientists thought we’d be eating food made from air – Popular Science

A Century Ago, Scientists Predicted We’d Be Eating Food Made from Air

August 4, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version